BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7913843)

  • 21. Role of autologous CD4+ T cell clones in human B non-Hodgkin's lymphoma: aborted activation and G1 blockade induced by cell-cell contact.
    Martin I; Bonnefoix T; Roucard C; Perron P; Lajmanovich A; Moine A; Leroux D; Sotto JJ; Garban F
    Eur J Immunol; 1999 Oct; 29(10):3188-95. PubMed ID: 10540330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex.
    Casamayor-Palleja M; Khan M; MacLennan IC
    J Exp Med; 1995 Apr; 181(4):1293-301. PubMed ID: 7699321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway.
    Karmann K; Hughes CC; Fanslow WC; Pober JS
    Eur J Immunol; 1996 Mar; 26(3):610-7. PubMed ID: 8605928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivity of monoclonal antibody B-ly7 with a subset of activated T cells and T-cell lymphomas.
    Visser L; Dabbagh L; Poppema S
    Hematol Pathol; 1992; 6(1):37-42. PubMed ID: 1601821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
    Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
    Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues.
    Gruss HJ; Herrmann F; Gattei V; Gloghini A; Pinto A; Carbone A
    Leuk Lymphoma; 1997 Feb; 24(5-6):393-422. PubMed ID: 9086433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model system for T-lymphocyte differentiation: regulation of CD4 and CD8 gene expression in SL12.4 T-lymphoma cell clones.
    Wilkinson MF; Fong AM; Huynh H; Hays EF; MacLeod CL
    Mol Immunol; 1991; 28(1-2):57-68. PubMed ID: 1672730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis.
    Wagner DH; Stout RD; Suttles J
    Eur J Immunol; 1994 Dec; 24(12):3148-54. PubMed ID: 7528671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
    Lettesjö H; Burd GP; Mageed RA
    J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baboon T cell lymphomas expressing the B cell-associated surface proteins CD40 and Bgp95.
    Indzhiia LV; Yakovleva LA; Overbaugh J; Licciardi KA; Chikobava MG; Klotz IN; Torres R; Indzhiia VO; Lapin BA; Clark EA
    J Clin Immunol; 1992 May; 12(3):225-36. PubMed ID: 1383259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of CD40 ligand on T cell subsets. Implications for different roles of CD45RA+ and CD45RO+ cells in IgE production.
    Patel HR; Oshiba A; Jeppson JD; Gelfand EW
    J Immunol; 1996 Mar; 156(5):1781-87. PubMed ID: 8596027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
    Maestre L; García-García JF; Jiménez S; Reyes-García AI; García-González Á; Montes-Moreno S; Arribas AJ; González-García P; Caleiras E; Banham AH; Piris MÁ; Roncador G
    PLoS One; 2020; 15(2):e0229743. PubMed ID: 32106280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.
    Ayasoufi K; Fan R; Fairchild RL; Valujskikh A
    J Immunol; 2016 Apr; 196(7):3180-90. PubMed ID: 26912319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.
    Roy M; Waldschmidt T; Aruffo A; Ledbetter JA; Noelle RJ
    J Immunol; 1993 Sep; 151(5):2497-510. PubMed ID: 8103067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
    Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
    Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.